Skip to main content
Cipla set to launch Favipiravir drug for treatment of Covid-19 patients - Livemint 24-Jul-2020
Cipla set to launch Favipiravir drug for treatment of Covid-19 patients - Livemint
An off-patent anti-viral drug, Favipiravir, originally discovered by Fuji Pharma in Japan, has shown promise in clinical trials for treatment of Covid-19 patients, especially in mild and moderate cases
More...